Texas Oncology-Northeast Texas — Longview, Texas

Texas Oncology-Northeast Texas is a clinical research site located in Longview, Texas, United States 75601.

Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-Northeast Texas has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Breast Cancer, Breast Neoplasms, Peripheral T-cell Lymphoma.

Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Northeast Texas?

Texas Oncology-Northeast Texas has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Northeast Texas conducted?

Texas Oncology-Northeast Texas has 2 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Breast Neoplasms, Peripheral T-cell Lymphoma.

Is Texas Oncology-Northeast Texas accredited by Crixeo Health?

Texas Oncology-Northeast Texas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-Northeast Texas?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.